Reuters logo
9 months ago
BRIEF-Medivir continues osteoarthritis trial after third review
December 8, 2016 / 7:39 AM / 9 months ago

BRIEF-Medivir continues osteoarthritis trial after third review

Dec 8 (Reuters) - Medivir Ab

* Medivir says MIV-711 osteoarthritis trial: successful third independent review of safety data and trial continues without any modifications

* Says it is expected that data from MIV-711-201 will be available in the third quarter of 2017 and that data from the extension study will be available in the first half of 2018 Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below